# Caffeine and Cocaine

> **NCT00733993** · PHASE1,PHASE2 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 23 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** Caffeine 150 MG
- **DRUG:** Placebo
- **DRUG:** Amphetamine
- **DRUG:** Caffeine 300 MG

## Key facts

- **NCT ID:** NCT00733993
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-07
- **Final completion:** 2011-10
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2017-03-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00733993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00733993, "Caffeine and Cocaine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00733993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*